A (Agilent Technologies) Expected net earnings per share growth this year

A (agilent.com) - company brandmark

Tracking the annual EPS growth of Agilent Technologies (A) confirms the impact of university alliances and laboratory digitalization, while the 10.80 level indicates the parameter's status. The business is betting on recurring payments for services and consumables within the biopharma sector. High engineer loyalty and the hiring of bioinformaticians ensure the stable development of the R&D sector.

A: Agilent Technologies Earnings growth in current year 07/04/2022 - 11/14/2026

Comprehensive metric breakdowns and analytics for Agilent Technologies (A)

- business market valuation indicators:
Summary company analysis:Agilent Technologies, Inc. (A)
Brand item of Agilent Corp

The Agilent Technologies (A) business model is based on monetizing an extensive installed base of laboratory equipment through high-margin services and consumables. This trend is quantified by the year-over-year percentage difference in EPS, which measures the growth rate of net income per share, allowing investors to distinguish sustainable scaling of operational efficiency from short-term, one-off spikes in profitability.

Key competitors

Net earnings per share change in current year Quest Diagnostics Inc. DGX|ILMN (Illumina Corp) - Earnings growth in current year|Exact Sciences Inc. (EXAS) - Expected net earnings per share growth this year|Earnings per share growth in current year Revvity, Inc. (RVTY)|Earnings per share growth in current year BIO (bio-rad.com)|Earnings growth in current year NNNN (Anbio)|Sotera Health Corp (SHC) - Earnings per share growth rate in current year|QDEL - Earnings per share growth in current year|OPK (OPKO Health Corp.) - Earnings per share growth this year|CDNA (caredx.com) - Net earnings per share growth this year|MRVI: Net earnings per one share growth for the current year|Net earnings per share growth this year FLGT|LAB: Earnings per share increase in current year|Net earnings per share growth this year CTKB (Cytek Bio)|Net earnings per one share growth for the current year OSUR|Earnings growth in current year XGN (Exagen)|mdxhealth.com (MDXH) - Earnings per share growth rate in current year|Lucid Diagnostics - Earnings growth in current year|Prenetics Global (PRE) - Net earnings per share growth this year|IMDX: Earnings growth in current year|Trinity Biotech - Earnings per share increase in current year|Earnings per share growth in current year ProPhase Labs, Inc.|Earnings per share growth this year AIMD (ainos.com)|Earnings per share growth in current year Co-Diagnostics (CODX)|HSCS - Earnings per share growth rate in current year|Earnings per share growth in current year Biomerica, Inc BMRA|Cardio Diagnostics Holdings Inc. - Earnings per share growth in current year|ONCO - Earnings per share growth in current year|Earnings per share growth rate in current year viraxbiolabs.com|BJDX: Earnings growth in current year|Net earnings per share change in current year Aspira Women's Health, Inc. AWH|AXDX (Accelerate Diagnostics, Inc) - Earnings growth in current year|CENTOGENE N.V. (CNTG) - Expected net earnings per share growth this year|Earnings growth in current year ENZ|FRES - Earnings per share growth rate in current year|Earnings per share growth in current year Genetic Technologies Limited GENE|Expected net earnings per share growth this year 23andMe Holding Co (ME)|Psychemedics Corp - Earnings growth in current year